← Back to Patent Explorer
US4908202A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of 2-oxo-1-pyrrolidineacetamide for the determination of the glomerular filtration rate in humans

Assignee: Sanofi Aventis Deutschland GmbH
•
Filing: 1989-01-23
•
Granted: 1990-03-13
•
Expires: 2009-01-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The use of 2-oxo-1-pyrrolidineacetamide for the determination of the glomerular filtration rate in humans.

Inventors

  • 👤 Hans-Ulrich Schulz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 23:49
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/145555; Y10T436/25; Y10T436/25375

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 67 words
A method for determining the glomerular filtration rate of a urine-producing subject which comprises administering a suitable known dose between about 800 and 300 mg. of piracetam to said subject, withdrawing blood samples from said subject at spaced time intervals after an initial latency time, and measuring the differences in the amounts of piracetam present in said blood samples over said time intervals and calculating the clearance.
Claim 2
Independent Claim 67 words
A method for determining the glomerular filtration rate of a urine-producing subject which comprises administering a suitable known dose between about 800 and 300 mg. of piracetam to said subject, withdrawing blood samples from said subject at spaced time intervals after an initial latency time, and measuring the differences in the amounts of piracetam present in said blood samples over said time intervals and calculating the clearance.
Claim 3
Dependent Claim 104 words
The method according to claim 1 for determining the glomerular filtration rate of a urine-producing subject which comprises the steps of: (a) administering said suitable known dose of piracetam to said subject (b) withdrawing blood samples from said subject at spaced time intervals after an initial latency time; (c) measuring the concentration of piracetam in each of said blood samples; (d) producing a concentration/time plot on a semi-logarithmic scale for each of said blood samples, and (e) calculating the clearance or elimination constant as a measurement of the amount of blood from which the piracetam has been removed in the kidneys in unit time.
Claim 4
Dependent Claim 17 words
The method according to claim 1 in which said known dose of piracetam is about 1200 mg.
Claim 5
Dependent Claim 20 words
The method according to claim 1 in which said blood samples are between about 1 and 2 ml in volume.
Claim 6
Dependent Claim 18 words
The method according to claim 1 in which said initial latency time is about 2 hours or more.
Claim 7
Dependent Claim 21 words
The method according to claim 1 in which the time interval between said blood samples is about 2.5 hours or more.
Claim 8
Dependent Claim 29 words
The method according to claim 1 in which the concentration of piracetam in each of the blood samples is determined by gas chromatography after extraction from the blood serum.
Claim 9
Dependent Claim 48 words
The method according to claim 2 in which the elimination constant (Ke) equals: ##EQU4## wherein ln C 1 and ln C 2 are the semilogarithmic values of the concentrations of piracetam in the first and second blood samples, respectively, and t 2 -t 1 equals the time interval.
Claim 10
Dependent Claim 31 words
The method according to claim 8 in which total body clearance of the piracetam, in terms of ml/min equals ##EQU5## wherein Vd equals the volume of distribution of piracetam in milliliters.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-03-12 1993-09-11 1994-03-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-03-12 1997-09-11 1998-03-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-03-12 2001-09-11 2002-03-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag